Skip to main content

Table 2 Intravenous iron prescribing practices

From: The use of intravenous iron in pregnancy: for whom and when? A survey of Australian and New Zealand obstetricians

Question (n = number of responses) Frequency (n) Percentage (%)
Prescribe IV iron in pregnancy (n = 444)
 Yes 426 95.9
 No 18 4.1
Prescribe IV iron postpartum (n = 429)
 Yes 364 84.8
 No 65 15.2
Location of IV iron administration (n = 421)
 Hospital 386 91.7
 Non-hospital 4 1.0
 Both 31 7.4
Number of infusions prescribed in pregnancy and/or postpartum per annum (n = 425)
  < 10 132 31.1
 10–19 107 25.2
 20–29 80 18.8
 30 or more 97 22.8
 Don’t prescribe 9 2.1
IV preparation prescribed (n = 425)a
 Ferric carboxymaltose (Ferinject) 381 89.6
 Iron polymaltose (Ferrosig, Ferrum-H) 54 12.7
 Don’t know 16 3.8
 Iron sucrose (Venofer) 11 2.6
 Othera 7 1.6
Gestation range of IV iron prescribing in IDAP (n = 419)b
 Prescribe during pregnancy 410 97.9
  < 13 weeks 35 8.4
 13–27 weeks 145 34.6
  ≥ 28 weeks 406 96.9
 Do not prescribe in pregnancy 9 2.1
Gestation range of IV iron prescribing in pregnancy for ID without anaemia (n = 413)7
 Prescribe during pregnancy 220 53.3
  < 13 weeks 14 3.4
 13–27 weeks 51 12.3
  ≥ 28 weeks 220 53.3
 Do not prescribe 193 46.7
  1. Abbreviations: IV intravenous; IDAP iron deficiency anaemia in pregnancy; ID iron deficiency. Superscript: F Fisher’s Exact; C Pearson’s Chi-Squared
  2. aNil alternative infusions specified
  3. bParticipants could select multiple ranges